{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000086","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.848591+00:00","generated_at":"2026-05-31T20:54:14.551186+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifecore Biomedical cuts 46 jobs (9% of workforce); expects $1.0M in severance costs","bullets":["Workforce Reduction Plan eliminates 46 full-time employees, approximately 9% of total workforce.","Estimated termination benefit costs of ~$1.0 million, primarily one-time severance.","Costs to be incurred in Q1 FY2025 and paid during Q1 and Q2 of fiscal 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000086","json":"https://secwatch.observer/filing/0001005286-24-000086.json","markdown":"https://secwatch.observer/filing/0001005286-24-000086.md","text":"https://secwatch.observer/filing/0001005286-24-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000086/0001005286-24-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000086/lndc-20240708.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:54:14.551186+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20208d7cf9f259b7b4bcc2a947ac2650e2c81d7c","claim":"LIFECORE BIOMEDICAL, INC. DE announced a restructuring with charges of approximately $1.0 million (46 full-time employees of the Company, representing approximately 9% of the Company’s workforce).","evidence_excerpt":"On July 8, 2024, Lifecore Biomedical, Inc. (the “Company”) determined to implement a strategic reduction of the Company’s workforce (the “Workforce Reduction Plan”) to terminate 46 full-time employees of the Company, representing approximately 9% of the Company’s workforce, as part of an initiative to strategically optimize the Company’s cost structure. In connection with the Workforce Reduction Plan, the Company estimates that it will incur termination benefit costs of approximately $1.0 million, which primarily consist of one-time severance benefits.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000086/0001005286-24-000086-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $1.0 million"},{"label":"Headcount","value":"46 full-time employees of the Company, representing approximately 9% of the Company’s workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}